Islet amyloid polypeptide: The cause of type-2 diabetes?
- 31 December 1991
- journal article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 2 (6) , 203-206
- https://doi.org/10.1016/1043-2760(91)90025-i
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocinJournal of Endocrinology, 1990
- Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humansDiabetes, 1990
- Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetesBiochemical and Biophysical Research Communications, 1990
- Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitusThe Lancet, 1990
- Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreasBiochemical and Biophysical Research Communications, 1990
- The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in catsBiochemical and Biophysical Research Communications, 1990
- AMYLIN AND AMYLIN-AMIDE LACK AN ACUTE EFFECT ON BLOOD GLUCOSE AND INSULINJournal of Endocrinology, 1990
- Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in manDiabetologia, 1990
- Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetesDiabetologia, 1989
- In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbitBiochemical and Biophysical Research Communications, 1989